ACHN - Achillion Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
270,977
331,845
77,261
81,725
Short Term Investments
221,148
256,578
286,558
377,616
Total Cash
270,977
331,845
363,819
459,341
Net Receivables
350
60
15,256
506
Inventory
-
-
-
-
Other Current Assets
343
465
416
269
Total Current Assets
270,977
331,845
382,535
462,588
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
11,277
10,876
10,612
8,033
Accumulated Depreciation
-9,140
-8,060
-7,133
-6,298
Net property, plant and equipment
2,137
2,816
3,479
1,735
Equity and other investments
0
30,511
27,657
-
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
341
348
204
202
Total non-current assets
6,881
5,768
31,340
1,937
Total Assets
277,858
337,613
413,875
464,525
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
131
170
351
223
Accounts Payable
2,335
5,253
7,002
4,133
Taxes payable
-
-
-
-
Accrued liabilities
4,983
3,447
2,957
10,302
Deferred revenues
-
-
-
-
Other Current Liabilities
-17
0
-149
0
Total Current Liabilities
11,829
12,884
13,971
14,658
Non-current liabilities
Long Term Debt
-
131
301
231
Deferred taxes liabilities
-
-
-
-
Deferred revenues
-
-
-
-
Other long-term liabilities
17
83
149
0
Total non-current liabilities
17
214
450
231
Total Liabilities
11,846
13,098
14,421
14,889
Stockholders' Equity
Common Stock
139
138
137
137
Retained Earnings
-672,926
-602,654
-517,418
-455,712
Accumulated other comprehensive income
-199
-389
151
-45
Total stockholders' equity
266,012
324,515
399,454
449,636
Total liabilities and stockholders' equity
277,858
337,613
413,875
464,525